Michael Korengold named chair of PanCAN board of directors; Linda Amuso named to board

July 15, 2022

Vol.48 No.28

DOWNLOAD PDF TABLE OF CONTENTS

Michael Korengold, president and CEO of Enhanced Capital Partners, was named chair of the Pancreatic Cancer Action Network Board of Directors.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

DOWNLOAD THE PDF

Table of Contents

YOU MAY BE INTERESTED IN

In Brief

Anna Berkenblit named chief scientific and medical officer of PanCAN

Anna Berkenblit, a clinical oncologist and drug developer, was named the first-ever chief scientific and medical officer of the Pancreatic Cancer Action Network.

April 05, 2024

Vol.50 No.14

Drugs & Targets

PanCAN and the Global Coalition for Adaptive Research form alliance to accelerate pancreatic cancer treatments

The Pancreatic Cancer Action Network, or PanCAN, and the Global Coalition for Adaptive Research formed a strategic alliance to further advance research efforts for pancreatic cancer.

January 12, 2024

Vol.50 No.02